Dabigatran etexilate Enrolling by Invitation Phase 4 Trials for Left Atrial Appendage Thrombosis / Device Related Thrombus / Watchman LAA Closure Device / Nonvalvular Atrial Fibrillation Prevention

IndicationsStatusPurposePhase
Enrolling by InvitationPrevention4
clinicaltrials.gov IdentifierTitleDrugs
NCT03539055Efficacy of Short Term Dabigatran Etexilate Followed by Aspirin Monotherapy After LAA (Left Atrial Appendage) Device Closure (the DEA-LAA Study).